Unidad de Pediatría, Hospital General de Agudos Vélez Sarsfield, Buenos Aires, Argentina.
Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina.
PLoS One. 2024 May 20;19(5):e0297767. doi: 10.1371/journal.pone.0297767. eCollection 2024.
Streptococcus pneumoniae is a leading cause of morbidity and mortality globally, causing bacteremic pneumonia, meningitis, sepsis, and other invasive pneumococcal diseases. Evidence supports nasopharyngeal pneumococcal carriage as a reservoir for transmission and precursor of pneumococcal disease.
To estimate the pneumococcal nasopharyngeal burden in all age groups in Latin America and the Caribbean (LAC) before, during, and after the introduction of pneumococcal vaccine conjugate (PVC).
Systematic literature review of international, regional, and country-published and unpublished data, together with reports including data from serotype distribution in nasopharyngeal carriage in children and adults from LAC countries following Cochrane methods. The protocol was registered in PROSPERO database (ID: CRD42023392097).
We included 54 studies with data on nasopharyngeal pneumococcal carriage and serotypes from 31,803 patients. In children under five years old, carriage was found in 41% and in adults over 65, it was 26%. During the study period, children under five showed a colonization proportion of 34% with PCV10 serotypes and 45% with PCV13 serotypes. When we analyze the carriage prevalence of PCV serotypes in all age groups between 1995 and 2019, serotypes included in PCV10 and those included in PCV13, both showed a decreasing trend along analysis by lustrum.
The data presented in this study highlights the need to establish national surveillance programs to monitor pneumococcal nasopharyngeal carriage to monitor serotype prevalence and replacement before and after including new pneumococcal vaccines in the region. In addition, to analyze differences in the prevalence of serotypes between countries, emphasize the importance of approaches to local realities to reduce IPD effectively.
肺炎链球菌是导致全球发病率和死亡率的主要原因,可引起菌血症性肺炎、脑膜炎、败血症和其他侵袭性肺炎球菌病。有证据表明鼻咽部肺炎球菌定植是传播的储库,也是肺炎球菌疾病的前身。
在引入肺炎球菌结合疫苗(PCV)之前、期间和之后,估计拉丁美洲和加勒比(LAC)所有年龄段人群的鼻咽部肺炎球菌负担。
系统检索国际、区域和国家发表和未发表的文献,以及包括 LAC 国家儿童和成人鼻咽部携带的血清型分布数据的报告,方法遵循 Cochrane 方法。该方案已在 PROSPERO 数据库中注册(ID:CRD42023392097)。
我们纳入了 54 项研究,这些研究提供了来自 31803 名患者的鼻咽部肺炎球菌携带和血清型数据。在 5 岁以下儿童中,携带率为 41%,65 岁以上的成年人中,携带率为 26%。在研究期间,5 岁以下儿童的 PCV10 血清型和 PCV13 血清型的定植比例分别为 34%和 45%。当我们分析 1995 年至 2019 年所有年龄段人群中 PCV 血清型的携带流行率时,PCV10 包含的血清型和 PCV13 包含的血清型都呈现出随着分析时间推移而逐渐下降的趋势。
本研究提供的数据强调了建立国家监测计划的必要性,以监测该地区引入新肺炎球菌疫苗前后鼻咽部肺炎球菌携带情况和血清型流行率变化。此外,分析各国之间血清型流行率的差异,强调了针对当地实际情况的方法的重要性,以有效降低侵袭性肺炎球菌病的发病率。